AI echo bundled with the LISENDO 880
FUJIFILM Healthcare Americas Corporation equips its LISENDO 880 cardiovascular ultrasound system with Us2.ai's FDA-cleared, fully automated echo analysis. Cardiologists and sonographers get device-grade image quality and AI-driven reporting in a single workflow.
Device-level AI analysis
FUJIFILM Healthcare Americas Corporation and Us2.ai have partnered to equip Fujifilm's LISENDO 880 cardiovascular ultrasound system with Us2.ai's AI-driven, automated clinical workflow solution. When used with the LISENDO 880, Us2.ai fully automates the analysis and reporting of echocardiograms and provides comprehensive cardiac measurements to support diagnosis.
Echo images are the gold standard for non-invasive cardiac imaging, but a full exam typically takes 40 to 90 minutes plus reporting time. Bundling AI analysis with the ultrasound platform itself removes the manual measurement step and lets cardiologists scan more patients without sacrificing image quality or guideline adherence.
Bundled at install
For sites buying or upgrading to the LISENDO 880, Us2.ai is available as an option directly from Fujifilm. Analysis runs automatically post-acquisition: the sonographer sees the structured report alongside the study without a separate workflow step or extra clicks.
Partnership highlights
- Full AI automation. Us2.ai's software analyzes echocardiography images from the LISENDO 880 without the need for manual measurements, streamlining workflow.
- Comprehensive cardiac analysis. The AI identifies heart chambers and calculates a full suite of clinically significant measurements automatically.
- Decision support tool. Disease indication conclusions aligned with international guidelines assist diagnosis and treatment planning.
Us2.ai is vendor-neutral: the software also works on echo images from any other ultrasound system. The Fujifilm partnership is one of several OEM and AI platform pathways by which Us2.ai is made available.
Echo images are the gold standard for non-invasive cardiac imaging, however the average time to complete an exam can take anywhere from 40 to 90 minutes, plus reporting time. AI has the ability to dramatically reduce this time burden, provide cardiologists with intelligent insights, and allow for more patients to get scanned.
Hideyuki Honda, Vice President, Ultrasound Business Unit and Business Development, FUJIFILM Healthcare Americas Corporation
Us2.ai on the ACC.25 Cardiac Wire Show
Cardiac Wire Show interview at ACC.25. The Fujifilm LISENDO 880 partnership is covered from the 3:02 mark.
Cleared indications
Us2.ai is FDA 510(k) cleared (K233676) and approved or registered in 28+ regulatory markets worldwide. The Fujifilm partnership is currently focused on the LISENDO 880 in the Americas; availability and cleared indications can differ between markets. For confirmation of which Us2.ai capabilities are cleared in a specific country, see Regulatory Status or contact us.
Continue Exploring
Bundle Us2.ai With Your LISENDO 880
Buying or upgrading to the LISENDO 880? Talk to our team about adding Us2.ai at install for fully automated echo analysis at the point of care.
Book a Demo